AstraZeneca

Page 2 of 13

Ryanair ceo Michael O'Leary sitting by a table
Success

Ryanair’s Michael O’Leary, who is up for a $108 million bonus, doesn’t see high CEO pay as a problem: ‘Footballers are getting half a million a week’

By
April 29, 2024
Pascal Soriot, CEO of AstraZeneca. Under Soriot, Astra has invested heavily in cancer drugs.
Retail

AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs

By Ashleigh Furlong and Bloomberg
April 25, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success

Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO

By
April 10, 2024
Stock traders from various companies work in five circular and one semi-circular trading floor at the Frankfurt Stock Exchange.
Finance

Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy

By
March 3, 2024
Nasal version of the Oxford/AstraZeneca COVID vaccine fails in U.K. trial
Health

Nasal version of the Oxford/AstraZeneca COVID vaccine fails in U.K. trial

By
October 11, 2022
Top AstraZeneca heart drug Farxiga sees potential to reach more patients
Health

Top AstraZeneca heart drug Farxiga sees potential to reach more patients

By
August 27, 2022
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
Health

The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic

By Sy Mukherjee and IDEA Pharma
April 20, 2022
Vaccine Antibody treatment Evusheld
Health

New drug that prevents you from catching COVID-19 gets green light in Europe — but it’s been in the U.S. for months and hardly anyone knows about it

By
March 29, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
Finance

Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?

By
December 29, 2021
A health care worker prepares a Moderna booster vaccine dose.
Health

Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries

By
December 27, 2021
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
Health

AstraZeneca finds its COVID booster delivers adequate protection against Omicron

By Suzi Ring and Bloomberg
December 23, 2021
Woman waiting to receive a vaccine booster shot.
Health

AstraZeneca COVID-19 vaccine’s protection against severe illness fades quickly, study finds

By
December 21, 2021
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
Health

EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares

By
December 20, 2021
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
Health

J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study

By
December 17, 2021
PM Visits Vaccination Centre In London
International

Omicron is making scientists redefine what it means to be ‘fully vaccinated’ against COVID

By
December 13, 2021

Most Popular